Amin Avinash 4

What Happened

• Avinash Amin (Director) disposed of a total of 42,500 Neuronetics (STIM) shares on 2026-06-15 via transfers (transaction code J). The transfers were reported at $0.00 per share (aggregate value $0) — not open-market sales. The transfers moved shares Amin received as director compensation into three Madryn funds per each fund’s partnership agreement.

Key Details

• Transaction date: 2026-06-15; Form 4 filed: 2026-06-17 (timely filing).
• Shares transferred: 2,934 to Madryn Health Partners II, LP; 34,932 to Madryn Health Partners II (Cayman Master), LP; 4,634 to Madryn Select Opportunities, LP — total 42,500 shares.
• Reported price/value: $0.00 per share; aggregate consideration: $0 (transfers were for no consideration).
• Transaction code: J (other acquisition/disposition — here, internal/fund transfers).
• Shares owned after the transaction: not specified in the provided filing excerpt.
• Footnotes: Transfers were of shares Amin received as director compensation and were made pursuant to each fund’s partnership agreement (no consideration).

Context

• These were transfers to affiliated investment vehicles rather than market sales — they move ownership among entities and do not necessarily signal insider intent to liquidate for cash. For retail investors, purchases are generally more informative than internal transfers; treat this as an administrative transfer of compensation rather than a sale.